Khoo Teck Puat- National University Children's Medical Institute, National University Health System, Singapore.
Khoo Teck Puat- National University Children's Medical Institute, National University Health System, Singapore.
Pediatr Neonatol. 2022 Nov;63(6):633-641. doi: 10.1016/j.pedneo.2022.05.010. Epub 2022 Aug 6.
Singapore was one of the first countries to begin COVID-19 vaccination with the BNT162b2 vaccine for adolescents aged 12-18 years. This study evaluates the incidence of COVID-19 vaccine related attendances to a Pediatric Emergency Department (PED) to understand post-vaccination health behaviors among adolescents.
This was a retrospective review of electronic medical records over a 4 month period, from the start of the adolescent vaccination drive to when more than 85% of this group had been fully vaccinated.
The incidence of COVID-19 vaccination-related presentations to our PED was 3.1% over 4 months (291 of 9387 PED attendances), with a peak daily incidence of 15.4% (14 of 91 attendances). Presentations were characterized by severity into: severe (3.4%), moderate (7.9%) or mild (88.7%) based on predefined criteria. The most common presenting complaints were chest pain (58.8%), dyspnea (28.2%) and palpitations (22.6%). Hospitalization was required in only 6.2% of attendances. Patients with moderate-severe presentations were 0.7 years older (p = 0.030), more likely to have underlying drug allergies (p = 0.048) and had higher rates of hospitalization (p < 0.005) compared to mild presentations. Despite concerns of cardiac inflammation, chest pain related attendances were less likely to be severe (p < 0.005) with reduced hospitalization need (p = 0.043) compared to other presentations. Investigations beyond clinical assessment comprised 91% of attendances, but abnormalities were only found in 6.4% cases.
Our study supports current evidence that COVID-19 vaccination is safe amongst adolescents. We highlight the health behaviors among adolescents post-vaccination, which is partly driven by media reports on vaccine side effects and an element of anxiety. While most of the presentations were mild, these can have implications on health resource utilization, particularly in an ongoing pandemic. As healthcare workers, we have an ongoing role to ensure accurate information on vaccine safety is communicated effectively to the public.
新加坡是最早为 12-18 岁青少年接种 BNT162b2 疫苗以预防 COVID-19 的国家之一。本研究评估了青少年前往儿科急诊部(PED)接种 COVID-19 疫苗相关就诊的发生率,以了解青少年接种疫苗后的健康行为。
这是一项回顾性电子病历研究,时间为 4 个月,从青少年疫苗接种开始到 85%以上的青少年完成全程接种。
PED 因 COVID-19 疫苗接种相关就诊的发生率为 4 个月内的 3.1%(9387 例 PED 就诊中有 291 例),峰值日发生率为 15.4%(91 例就诊中有 14 例)。根据预设标准,就诊的严重程度分为:严重(3.4%)、中度(7.9%)或轻度(88.7%)。最常见的主诉是胸痛(58.8%)、呼吸困难(28.2%)和心悸(22.6%)。仅需住院治疗的就诊比例为 6.2%。中度或重度就诊的患者年龄大 0.7 岁(p=0.030),更有可能有药物过敏史(p=0.048),且住院率更高(p<0.005)。尽管存在心脏炎症的担忧,但胸痛相关就诊的严重程度较低(p<0.005),住院需求减少(p=0.043),与其他就诊相比。除临床评估外,91%的就诊患者还进行了检查,但仅在 6.4%的病例中发现异常。
本研究支持目前关于 COVID-19 疫苗在青少年中安全的证据。我们强调了青少年接种疫苗后的健康行为,这在一定程度上是由媒体对疫苗副作用的报道和焦虑因素驱动的。尽管大多数就诊都是轻度的,但这可能会对卫生资源的利用产生影响,尤其是在持续的大流行期间。作为医疗保健工作者,我们有责任确保向公众有效传达疫苗安全性的准确信息。